Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.32B |
| 2 |
SCHR
Schwab Intermediately-Term US Treasury ETF
SCHR
|
+$1.22B |
| 3 |
Chevron
CVX
|
+$477M |
| 4 |
Pfizer
PFE
|
+$375M |
| 5 |
Amazon
AMZN
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$9.58B |
| 2 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.28B |
| 3 |
Schwab International Equity ETF
SCHF
|
+$4.53B |
| 4 |
Schwab U.S Small- Cap ETF
SCHA
|
+$4.13B |
| 5 |
Schwab Emerging Markets Equity ETF
SCHE
|
+$2.63B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.59% |
| 2 | Financials | 12.1% |
| 3 | Healthcare | 10.58% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZUO
2026
DELISTED
Zuora, Inc.
ZUO
| $9.94M | ﹤0.01% |
1,153,372
+4,432
| +0.4% | +$39.3K |
|
2027
Alignment Healthcare
ALHC
$2.87B
| $9.93M | ﹤0.01% |
839,695
+13,865
| +2% | +$131K |
|
2028
Astec Industries
ASTE
$1.24B
| $9.87M | ﹤0.01% |
308,881
-44,360
| -13% | -$1.43M |
|
2029
ProPetro Holding
PUMP
$1.37B
| $9.81M | ﹤0.01% |
1,281,081
-269,526
| -17% | -$2.2M |
|
2030
Core Laboratories
CLB
$509M
| $9.81M | ﹤0.01% |
529,522
-70,389
| -12% | -$1.41M |
|
2031
Unilever
UL
$138B
| $9.81M | ﹤0.01% |
134,246
+27,721
| +26% | +$1.92M |
|
2032
Spyre Therapeutics
SYRE
$8.72B
| $9.8M | ﹤0.01% |
333,275
+235,094
| +239% | +$6.55M |
|
2033
Capitol Federal Financial
CFFN
$1.13B
| $9.77M | ﹤0.01% |
1,673,095
-237,757
| -12% | -$1.4M |
|
2034
HSBC
HSBC
$366B
| $9.75M | ﹤0.01% |
215,748
+27,495
| +15% | +$1.19M |
|
|
SLNO
2035
DELISTED
Soleno Therapeutics
SLNO
| $9.72M | ﹤0.01% |
192,597
+130,080
| +208% | +$6.23M |
|
2036
Protolabs
PRLB
$2.08B
| $9.72M | ﹤0.01% |
330,798
-17,972
| -5% | -$548K |
|
2037
Standard Motor Products
SMP
$893M
| $9.71M | ﹤0.01% |
292,512
-33,436
| -10% | -$1.04M |
|
2038
Sphere Entertainment
SPHR
$5.69B
| $9.71M | ﹤0.01% |
219,792
+2,187
| +1% | +$94.1K |
|
2039
Ocular Therapeutix
OCUL
$1.88B
| $9.66M | ﹤0.01% |
1,110,460
+660,080
| +147% | +$5.44M |
|
2040
DXP Enterprises
DXPE
$2.65B
| $9.66M | ﹤0.01% |
181,022
-29,281
| -14% | -$1.47M |
|
2041
Sturm, Ruger & Co
RGR
$621M
| $9.66M | ﹤0.01% |
231,686
-40,573
| -15% | -$1.71M |
|
2042
RPC Inc
RES
$1.3B
| $9.6M | ﹤0.01% |
1,509,478
+106,108
| +8% | +$668K |
|
|
HSII
2043
DELISTED
Heidrick & Struggles
HSII
| $9.6M | ﹤0.01% |
247,011
-26,801
| -10% | -$969K |
|
2044
Center Bancorp
CNOB
$1.7B
| $9.58M | ﹤0.01% |
382,524
-39,706
| -9% | -$913K |
|
|
JAMF
2045
DELISTED
Jamf
JAMF
| $9.58M | ﹤0.01% |
552,266
+42,582
| +8% | +$757K |
|
2046
Trump Media & Technology Group
DJT
$2.79B
| $9.56M | ﹤0.01% |
595,159
+329,288
| +124% | +$7.98M |
|
2047
Community Health Systems
CYH
$406M
| $9.56M | ﹤0.01% |
1,574,190
-253,806
| -14% | -$1.24M |
|
2048
Tarsus Pharmaceuticals
TARS
$2.66B
| $9.54M | ﹤0.01% |
290,009
+28,130
| +11% | +$791K |
|
2049
BHP
BHP
$221B
| $9.51M | ﹤0.01% |
153,170
+22,677
| +17% | +$1.25M |
|
2050
TransAlta
TAC
$4B
| $9.49M | ﹤0.01% |
914,238
-45,222
| -5% | -$376K |
|
Similar funds
Charles Schwab's Q3 2024 Portfolio in Review
As of Q3 2024, Charles Schwab held 3,658 positions worth $524B, down 0.18% from $525B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab withdrew a net $33.1B in Q3 2024, closing 156 positions and reducing 1,005 holdings. Its most notable exit was Schwab US Large- Cap ETF, an estimated $9.58B position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Charles Schwab opened a new position in Shopify worth $194M.
- Charles Schwab's largest Q3 2024 buy was Shopify: 2,416,436 shares worth $194M.
- Charles Schwab added most to Apple in Q3 2024, an estimated $1.32B increase.
- Charles Schwab's biggest Q3 2024 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $958M.
- Charles Schwab fully exited Schwab US Large- Cap ETF in Q3 2024, selling an estimated $9.58B.
- Charles Schwab's ten largest holdings make up 21% of its $524B portfolio in Q3 2024.
- Charles Schwab opened 39 new positions and closed 156 in Q3 2024.
- Charles Schwab's portfolio value fell 0.18% quarter-over-quarter to $524B.
Based on Charles Schwab's 13F filing for Q3 2024, filed 12 Nov 2024.